Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development
- PMID: 12931207
- DOI: 10.1038/sj.mp.4001319
Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development
Abstract
Dysfunction of the prefrontal cortex in schizophrenia may be associated with abnormalities in synaptic structure and/or function and reflected in altered concentrations of proteins in presynaptic terminals and involved in synaptic plasticity (synaptobrevin/ vesicle-associated membrane protein (VAMP), synaptosomal-associated protein-25 (SNAP-25), syntaxin, synaptophysin and growth-associated protein-43 (GAP-43)). We examined the immunoreactivity of these synapse-associated proteins via quantitative immunoblotting in the prefrontal cortex of patients with schizophrenia (n=18) and in normal controls (n=23). We also tested the stability of these proteins across successive post-mortem intervals in rat brains (at 0, 3, 12, 24, 48, and 70 h). To investigate whether experimental manipulation of prefrontal cortical development in the rat alters prefrontal synaptic protein levels, we lesioned the ventral hippocampus of rats on postnatal day 7 and measured immunoreactivity of presynaptic proteins in the prefrontal cortex on postnatal day 70. VAMP immunoreactivity was lower in the schizophrenic patients by 22% (P<0.03). There were no differences in the immunoreactivity of any other proteins measured in schizophrenic patients as compared to the matched controls. Proteins were fairly stable up to 24 h and thereafter the abundance of most proteins examined was significantly reduced (falling to as low as 20% of baseline levels at 48-70 h). VAMP immunoreactivity was higher in the lesioned rats as compared to sham controls by 22% (P&<0.03). There were no significant differences between the lesioned rats and sham animals in any other presynaptic protein. These data suggest that apparently profound prefrontal cortical dysfunction in schizophrenia, as well as in an animal model of schizophrenia, may exist without gross changes in the abundance of many synaptic proteins but discrete changes in selected presynaptic molecules may be present.
Similar articles
-
Region and diagnosis-specific changes in synaptic proteins in schizophrenia and bipolar I disorder.Psychiatry Res. 2010 Jul 30;178(2):374-80. doi: 10.1016/j.psychres.2008.07.012. Epub 2010 May 21. Psychiatry Res. 2010. PMID: 20488553
-
Acute sublethal global hypoxia induces transient increase of GAP-43 immunoreactivity in the striatum of neonatal rats.Synapse. 2007 Mar;61(3):124-37. doi: 10.1002/syn.20353. Synapse. 2007. PMID: 17146769
-
Synaptobrevin-2-like immunoreactivity is associated with vesicles at synapses in rat circumvallate taste buds.J Comp Neurol. 2004 Mar 22;471(1):59-71. doi: 10.1002/cne.20021. J Comp Neurol. 2004. PMID: 14983476
-
[Proteins regulating neurotransmitter release of synaptic vesicles at nerve terminals].Sheng Li Ke Xue Jin Zhan. 2003 Jan;34(1):6-10. Sheng Li Ke Xue Jin Zhan. 2003. PMID: 12778801 Review. Chinese.
-
Translational and developmental perspective on N-methyl-D-aspartate synaptic deficits in schizophrenia.Dev Psychopathol. 2006 Summer;18(3):853-76. Dev Psychopathol. 2006. PMID: 17152404 Review.
Cited by
-
Differential expression of presynaptic genes in a rat model of postnatal hypoxia: relevance to schizophrenia.Eur Arch Psychiatry Clin Neurosci. 2010 Nov;260 Suppl 2(Suppl 2):S81-9. doi: 10.1007/s00406-010-0159-1. Epub 2010 Oct 14. Eur Arch Psychiatry Clin Neurosci. 2010. PMID: 20945070 Free PMC article.
-
Perinatal oxygen restriction does not result in reduced rat frontal cortex synaptophysin protein levels at adulthood as opposed to postmortem findings in schizophrenia.J Mol Neurosci. 2009 Jan;37(1):60-6. doi: 10.1007/s12031-008-9120-4. Epub 2008 Jul 15. J Mol Neurosci. 2009. PMID: 18626794
-
Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics.Eur Arch Psychiatry Clin Neurosci. 2008 Sep;258(6):335-44. doi: 10.1007/s00406-007-0800-9. Epub 2008 Mar 17. Eur Arch Psychiatry Clin Neurosci. 2008. PMID: 18347838 Clinical Trial.
-
Molecular profiling of antipsychotic drug function: convergent mechanisms in the pathology and treatment of psychiatric disorders.Mol Neurobiol. 2006 Oct;34(2):109-28. doi: 10.1385/MN:34:2:109. Mol Neurobiol. 2006. PMID: 17220533 Review.
-
Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia.BMC Psychiatry. 2009 Nov 16;9:71. doi: 10.1186/1471-244X-9-71. BMC Psychiatry. 2009. PMID: 19917116 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous